Basic information Safety Supplier Related

PROTEIN KINASE A INHIBITOR 14-22 AMIDE, CELL-PERMEABLE, MYRISTOYLATED

Basic information Safety Supplier Related

PROTEIN KINASE A INHIBITOR 14-22 AMIDE, CELL-PERMEABLE, MYRISTOYLATED Basic information

Product Name:
PROTEIN KINASE A INHIBITOR 14-22 AMIDE, CELL-PERMEABLE, MYRISTOYLATED
Synonyms:
  • PKI 14-22 AMIDE, CELL-PERMEABLE
  • PKI 14-22 AMIDE, MYRISTOYLATED
  • PROTEIN KINASE A INHIBITOR 14-22 AMIDE, CELL-PERMEABLE, MYRISTOYLATED
  • PROTEIN KINASE A INHIBITOR 14-22 AMIDE, MYRISTOYLATED
  • MYRISTOYLATED PKI (14-22) AMIDE
  • MYRISTOYLATED PROTEIN KINASE A INHIBITOR AMIDE 14-22, CELL-PERMEABLE
  • MYR-GRTGRRNAI-NH2
  • L-Isoleucinamide, N-(1-oxotetradecyl)glycyl-L-arginyl-L-threonylglycyl-L-arginyl-L-arginyl-L-asparaginyl-L-alanyl-
CAS:
201422-03-9
MF:
C53H100N20O12
MW:
1209.49
Mol File:
201422-03-9.mol
More
Less

PROTEIN KINASE A INHIBITOR 14-22 AMIDE, CELL-PERMEABLE, MYRISTOYLATED Chemical Properties

storage temp. 
-20°C
solubility 
Soluble to 1 mg/ml in DMSO
form 
Solid.
color 
White to off-white
More
Less

PROTEIN KINASE A INHIBITOR 14-22 AMIDE, CELL-PERMEABLE, MYRISTOYLATED Usage And Synthesis

Biological Activity

myristoylated pki (14-22) amide is an effective inhibitor of camp-dependent protein kinase (pka) and blocks hyperalgesia produced by spinal administration of 8-bromo-camp. [1]pkas are the major mediators of camp signaling in eukaryotes. pkas play an important role in several biological processes such as gene expression, apoptosis, tissue differentiation and cellular proliferation. pkas play these functions through the phosphorylation of protein substrates at serine/threonine residues. [2]pkas play a key role in neutrophil phagocytosis. camp/pkas regulate f-actin reorganization during receptor-mediated phagocytosis, particularly triggered by igg-fcr interaction. myristoylated pki 14-22 amide reduced the igg-mediated phagocytic response in a manner of dose-dependent. when the concentration is higher than 10 μm, pki 14-22 amide can inhibit neutrophil adhesion, which make the phagocytosis measurements impossible to perform. [1]because the unregulated activity of pka in mammalian cells has been implicated in the pathogenesis of several types of cancer, the development of pki (14–22) amide has been pursued as a potential treatment for these types of cancer and many other diseases related with pkas.[1,2]

storage

Store at -20°C

References

[1] ydrenius l1, majeed m, etal. , activation of camp-dependent protein kinase is necessary for actin rearrangements in human neutrophils during phagocytosis. j leukoc biol. 2000 apr;67(4):520-8.
[2] swierczewski be, davies sj. developmental regulation of protein kinase a expression and activity in schistosoma mansoni. int j parasitol. 2010 jul;40(8):929-35.

PROTEIN KINASE A INHIBITOR 14-22 AMIDE, CELL-PERMEABLE, MYRISTOYLATEDSupplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Creative Peptides
Tel
Email
info@creative-peptides.com
Nanjing Leon Biological Technology Co., Ltd.
Tel
17705183659
Email
sales@njleonbiotech.com
Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Email
Eric@peptidego.com
BOC Sciences
Tel
16314854226; +16314854226
Email
inquiry@bocsci.com